Skip to main content
. 2022 Nov 21;41(4):417–427. doi: 10.1007/s11604-022-01363-1

Table 1.

Detailed clinical statistics of patients with PDAC and AIP

Variable PDAC (n = 64) AIP (n = 48)
Patients’ sex (male/female) 35/29 43/5
Patients’ age (min/max/mean ± SD) 32/88/66 ± 11.3 37/90/65 ± 12.0
Uptake status (focal/diffuse) 36/28 19/29
SUV (min/max/median) 2.71/24.62/9.41 1.34/6.11/3.58

AIP autoimmune pancreatitis, PDAC pancreatic ductal adenocarcinoma, SUV standardized uptake values

HHS Vulnerability Disclosure